Abstract
We investigated the clinical outcome and current therapeutic management of ischemic stroke in elderly patients in different neurological wards throughout Italy. Twelve centers in 10 Italian regions were involved. The clinical and instrumental data were prospectively collected for 335 patients 65 years or older, presenting in a 12-months period. At the multivariate analysis, death was associated with the presence of total anterior circulation infarct and the use of antiedema agents. Stroke-related disability was related to female sex, unified stroke scale (USS) scores at entry and mini-mental state examination (MMSE) scores at the 1-months follow-up. The majority of patients (70%) received antiplatelets to prevent stroke recurrence. Very elderly (≥80 years) patients had worse presentation and prognosis than less elderly stroke victims (<80 years). Age played an important role in the therapeutic approach to stroke: while antiplatelets were widely used, oral anticoagulants were underused even when specifically indicated.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Consortia
Additional information
Received: 6 November 2001 / Accepted in revised form: 28 February 2002
Rights and permissions
About this article
Cite this article
The Italian Study of Pharmacological Treatment of Acute Stroke in the Elderly (SPASE)-I Group., Altieri, M. SPASE-I: a multicenter observational study on pharmacological treatment of acute stroke in the elderly. Neurol Sci 23, 23–28 (2002). https://doi.org/10.1007/s100720200019
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100720200019